amlodipine besylate; atorvastatin calcium · Pharmacia · NDA 021540

Caduet

Earliest generic entry, as listed · earliest of 11 marketed strengths
Open now

No unexpired patents or exclusivities are listed for this product.

Listed patents · 0 unexpired

No unexpired patents listed.

Exclusivities · 0 unexpired

No unexpired exclusivities listed.

Paragraph IV certifications · 0

No Paragraph IV certification listed by FDA for this drug.

The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.

Event history

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.

Products covered · 11

NDA · productFormStrengthListed expiry
021540 · 001 · RLDtablet, oralEQ 5MG BASE;EQ 10MG BASEopen
021540 · 002 · RLDtablet, oralEQ 5MG BASE;EQ 20MG BASEopen
021540 · 003 · RLDtablet, oralEQ 5MG BASE;EQ 40MG BASEopen
021540 · 004 · RLDtablet, oralEQ 5MG BASE;EQ 80MG BASEopen
021540 · 005 · RLDtablet, oralEQ 10MG BASE;EQ 10MG BASEopen
021540 · 006 · RLDtablet, oralEQ 10MG BASE;EQ 20MG BASEopen
021540 · 007 · RLDtablet, oralEQ 10MG BASE;EQ 40MG BASEopen
021540 · 008 · RLDtablet, oralEQ 10MG BASE;EQ 80MG BASEopen
021540 · 009 · RLDtablet, oralEQ 2.5MG BASE;EQ 10MG BASEopen
021540 · 010 · RLDtablet, oralEQ 2.5MG BASE;EQ 20MG BASEopen
021540 · 011 · RLDtablet, oralEQ 2.5MG BASE;EQ 40MG BASEopen